InFLAMES Flagship
- Classification of ischemia from myocardial polar maps in 15 O-H 2 O cardiac perfusion imaging using a convolutional neural network (2022)
- Clever-1 positive macrophages in breast cancer (2022)
- CLEVER-1 targeting antibody, bexmarilimab, supports HLA-DR expression and alters ex vivo responsiveness to azacitidine and venetoclax in myeloid malignancies (2025)
- Clinical and biochemical associations of urinary metabolites: quantitative epidemiological approach on renal-cardiometabolic biomarkers (2023)
- Clinical care advice for monitoring of islet autoantibody positive individuals with presymptomatic type 1 diabetes (2024)
- Clinical development and proof of principle testing of new regenerative vascular endothelial growth factor-D therapy for refractory angina: rationale and design of the phase 2 ReGenHeart trial (2024)
- Clinical landscape of macrophage-reprogramming cancer immunotherapies (2024)
- Clinical likelihood models calibrated against observed obstructive coronary artery disease on computed tomography angiography (2025)
- Clinical Likelihood Prediction of Hemodynamically Obstructive Coronary Artery Disease in Patients With Stable Chest Pain (2024)
- Clinical risk prediction, coronary computed tomography angiography, and cardiovascular events in new-onset chest pain: the PROMISE and SCOT-HEART trials (2024)





